Association of pyridoxal kinase and Parkinson disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. The Therapeutic Potential of Vitamins B1, B3 and B6 in Charcot-Marie-Tooth Disease with the Compromised Status of Vitamin-Dependent Processes.Biology · 2023
   Review
2. Vitamin B₆ and Its Role in Cell Metabolism and Physiology.Cells · 2018
   Review
3. Current status and future directions of gene expression profiling in Parkinson's disease.Neurobiology of disease · 2012
   Review
4. Genetics of Parkinson disease and essential tremor.Current opinion in neurology · 2010
   Review

Corrections and comments

• Comment on
  Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene.2009

Authors and funding

17 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as